DOUGLAS ALEXANDER: Open Payments
NPI 1639673452 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 8 payments from 7 companies in 2025. Trend: 2023 $203 · 2024 $0 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $78 |
| Teva Pharmaceuticals USA, Inc. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Alkermes, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: Qelbree, UZEDY, ABILIFY MAINTENA, ARISTADA, FANAPT, COBENFY, SPRAVATO.
Industry payments across LA — which companies pay providers there.
